Beet Juice and Fatty Liver: Evidence and Safety

Beet juice and fatty liver disease is a topic attracting growing interest, with early research suggesting beetroot's natural compounds may offer supportive benefits for liver health. Fatty liver disease, now clinically termed metabolic dysfunction-associated steatotic liver disease (MASLD), affects around one in three adults in the UK and is closely linked to obesity, type 2 diabetes and raised cholesterol. Beetroot contains betalains, dietary nitrates and betaine, all of which have shown potential to reduce oxidative stress and inflammation in preliminary studies. This article examines what the evidence actually shows, how much beet juice is safe to consume, and what proven lifestyle strategies can help manage a fatty liver.

Can beet juice really help with a fatty liver?

Beet juice is not a proven treatment for fatty liver disease, but its active compounds, including betalains and betaine, may offer supportive benefits as part of a balanced diet alongside established lifestyle interventions.

Beet juice shows early promise as a dietary support for liver health, but it is not a proven treatment for fatty liver disease and should not replace medical advice or lifestyle changes. Fatty liver disease, known clinically as metabolic dysfunction-associated steatotic liver disease (MASLD), occurs when excess fat accumulates in liver cells. It is estimated to affect around one in three adults in the UK and is closely linked to obesity, type 2 diabetes, high blood pressure and raised cholesterol. A separate condition, alcohol-related fatty liver disease (ALD), is driven primarily by heavy alcohol use and is distinct from MASLD, though both involve fat accumulation in the liver.

Beetroot contains several biologically active compounds, including betalains (the pigments responsible for its deep red colour), dietary nitrates and betaine. These compounds have attracted scientific interest because of their potential to reduce oxidative stress and inflammation, both of which play a role in the progression of fatty liver disease. However, the evidence supporting these effects in humans remains limited and preliminary.

It is important to understand that beet juice is a food, not a medicine. It has not been authorised by the MHRA for any therapeutic indication, and NICE has not issued guidance recommending it as a treatment. However, as part of a balanced, plant-rich diet, it may offer supportive benefits alongside established lifestyle interventions. Anyone considering dietary changes to manage a liver condition should discuss this with their GP or a registered dietitian first.

What does the evidence say about beetroot and liver health?

Small studies report modest reductions in liver enzymes with beetroot juice, but no large randomised controlled trial has confirmed a clinically meaningful benefit, so findings remain preliminary.

Preclinical and small human studies suggest that beetroot and its extracts may help reduce markers of liver inflammation and fat accumulation, though the evidence base remains limited and largely preliminary. Laboratory and animal studies have demonstrated that betalains and betaine can reduce lipid peroxidation and lower triglyceride levels in liver tissue.^[2] Betaine, in particular, is a methyl donor involved in fat metabolism and has been studied in the context of non-alcoholic fatty liver disease.^[2]

A small number of human trials have examined beetroot juice or beetroot extract in people with elevated liver enzymes or metabolic risk factors. Some have reported modest reductions in alanine aminotransferase (ALT) and aspartate aminotransferase (AST), which are blood markers of liver stress. However, these studies have generally involved small participant numbers, short durations and variable methodologies, making it difficult to draw firm conclusions. No large, well-designed randomised controlled trial has yet confirmed a clinically meaningful benefit of beetroot juice on liver fat or fibrosis in humans.

The nitrate content of beetroot is also of interest. Dietary nitrates are converted in the body to nitric oxide, which supports blood vessel function.^[3] Whether this translates to any meaningful benefit for liver health in humans has not been confirmed in robust clinical trials, and this mechanism should be regarded as unproven at present.

In summary, the current evidence is intriguing but not conclusive. Larger, well-designed randomised controlled trials are needed before beetroot juice can be recommended as a specific intervention for fatty liver disease. Patients should treat existing findings as hypothesis-generating rather than definitive.

How much beet juice should you drink, and is it safe?

No UK regulatory body has established a recommended dose of beet juice for liver health; moderate consumption is generally safe for healthy adults, but those with kidney disease, diabetes or hypertension should seek GP advice first.

There is no officially recommended dose of beet juice for liver health, as no regulatory body or clinical guideline has established one. Research studies have used a range of quantities, but these are research protocols rather than clinical prescriptions, and no authoritative UK body has defined a safe or effective daily amount for this purpose.

For most healthy adults, moderate consumption of beet juice as part of a varied diet is generally considered safe. However, there are some important considerations:

• Beeturia: Beet juice can turn urine and stools pink or red. This is harmless but can be alarming if unexpected.

• Kidney stones: Beetroot is high in oxalates. People with a history of calcium oxalate kidney stones should limit intake and seek advice from their GP or a registered dietitian.

• Blood pressure: The nitrate content of beet juice can lower blood pressure.^[4][5] People already taking antihypertensive medication should discuss this with their doctor before consuming beet juice regularly.

• Blood sugar: People with type 2 diabetes should be aware that beetroot juice contains natural sugars and should monitor their response and consult their diabetes care team.

• Kidney disease: Beetroot juice is relatively high in potassium. People with chronic kidney disease or those advised to limit potassium intake should seek advice from their GP or renal dietitian before consuming it regularly.

• Digestive effects: Some people experience bloating or loose stools with larger quantities.

Beet juice is not suitable as a replacement for prescribed medication or medical treatment. If you have a diagnosed liver condition, always consult your GP or hepatology team before making significant dietary changes.

What else can help reduce fat on the liver alongside diet changes?

Losing 7 to 10 per cent of body weight, following a Mediterranean-style diet and undertaking at least 150 minutes of moderate exercise weekly are the most evidence-based strategies for reducing liver fat, per NICE NG49.

The most effective interventions for reducing liver fat are sustained weight loss, regular physical activity and a healthy overall diet. NICE guideline NG49 on non-alcoholic fatty liver disease (the current UK guideline, which covers the condition now also referred to as MASLD) supports these approaches. Evidence consistently shows that losing around 7 to 10 per cent of body weight can significantly reduce liver fat and inflammation, and in some cases reverse early fibrosis, as reflected in NICE NG49 and EASL 2024 clinical practice guidelines.^[7][8]

Key lifestyle strategies include:

• Diet: A Mediterranean-style diet, rich in vegetables, legumes, wholegrains, oily fish and olive oil, has the strongest evidence base for liver health. Reducing ultra-processed foods, added sugars and saturated fats is particularly important.

• Physical activity: Both aerobic exercise and resistance training have been shown to reduce liver fat independently of weight loss.^[12][13] The UK Chief Medical Officers' guidelines recommend at least 150 minutes of moderate-intensity activity per week.^[15][16]

• Alcohol: For alcohol-related fatty liver disease, reducing or stopping alcohol consumption is the single most important intervention. NHS Alcohol Support services and your GP can provide guidance.

• Managing associated conditions: Controlling blood glucose, blood pressure and cholesterol through medication and lifestyle reduces the metabolic burden on the liver.

For people who are eligible and where lifestyle changes alone are insufficient, a GP may refer to specialist weight management services. Access to these services depends on local Integrated Care Board commissioning and specialist pathways. Tirzepatide (Mounjaro), which is MHRA-authorised in the UK for both type 2 diabetes and chronic weight management, is one option a prescriber may consider after an online consultation with Bolt Pharmacy, a GPhC-registered UK online pharmacy, and is only prescribed where it is clinically appropriate.^[18][19] Other licensed options include semaglutide (Wegovy, available in doses up to 2.4 mg and 7.2 mg weekly) and liraglutide (Saxenda). This list is not exhaustive; other licensed medicines exist and a prescriber will advise on the most appropriate option for each individual.

If you experience suspected side effects from any medicine, you can report these to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

When should you see a GP about a fatty liver?

See your GP if you have risk factors such as obesity or type 2 diabetes, or if you experience symptoms including fatigue, upper right abdominal discomfort, jaundice or abdominal swelling, as early detection significantly improves outcomes.

You should see your GP if you have been told you have a fatty liver, if you have risk factors such as obesity, type 2 diabetes or high cholesterol, or if you experience symptoms that may suggest liver disease. Fatty liver disease is often silent in its early stages and is frequently detected incidentally during blood tests or an abdominal ultrasound carried out for another reason.

Contact your GP if you notice any of the following:

• Persistent fatigue or unexplained tiredness

• Discomfort or a dull ache in the upper right abdomen

• Unexplained weight loss

• Yellowing of the skin or whites of the eyes (jaundice)

• Dark urine or pale stools

• Severe or persistent itching

• Easy bruising or bleeding

• Swelling of the abdomen or legs

• Confusion or difficulty concentrating, which can indicate advanced liver disease

Jaundice, significant abdominal swelling or sudden confusion warrant prompt medical attention. Contact NHS 111 for urgent advice if you are unsure whether your symptoms need same-day assessment, or go to your nearest accident and emergency department if you are seriously unwell.

Your GP can arrange liver function tests, a liver ultrasound and non-invasive fibrosis scoring (such as the FIB-4 index, used in UK primary care per NICE NG49) and, where appropriate, a FibroScan or referral to a hepatologist to assess the degree of liver damage. Early detection and intervention significantly improve outcomes. Dietary measures such as beet juice may complement a healthy lifestyle, but they are not a substitute for medical monitoring and, where indicated, treatment. Regular follow-up with your GP or liver specialist is essential if you have a confirmed diagnosis of fatty liver disease.

Scientific References

1. Epidemiology of metabolic dysfunction-associated steatotic liver disease.
2. Comparing effects of beetroot juice and Mediterranean diet on liver enzymes and sonographic appearance in patients with non-alcoholic fatty liver disease: a randomized control trials.
3. The effects of dietary nitrate on blood pressure and endothelial function: a review of human intervention studies.
4. Effects of beetroot juice on blood pressure in hypertension according to European Society of Hypertension Guidelines: A systematic review and meta-analysis.
5. Effects of chronic nitrate supplementation on blood pressure in adults: a systematic review and meta-analysis of randomized clinical trials.
6. Effectiveness of dietary inorganic nitrate for lowering blood pressure in hypertensive adults: a systematic review.
7. Metabolic dysfunction-associated steatotic liver disease (MASLD): NICE guideline NG49.
8. Non-alcoholic fatty liver disease (NAFLD).
9. The impact of dietary interventions on liver health biomarkers in individuals with MASLD: a systematic literature review and meta-analysis of randomized controlled trials.
10. Comparative efficacy of different diet modalities on metabolic profiles and liver functions in metabolic dysfunction-associated fatty liver disease: a network meta-analysis.
11. A systematic review and meta-analysis of randomized controlled trials: effects of Mediterranean diet and low-fat diet on liver enzymes and liver fat content of NAFLD.
12. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of body weight.
13. Structured Exercise Interventions and Hepatic-Metabolic Outcomes in Adults with MASLD: A Narrative Review of Randomized Controlled Trials.
14. Exercise improves surrogate measures of liver histological response in metabolic dysfunction-associated steatotic liver disease.
15. Physical activity guidelines: UK Chief Medical Officers' report.
16. UK Chief Medical Officers' physical activity guidelines.
17. Physical activity guidelines for adults aged 19 to 64.
18. MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss.
19. Tirzepatide.
20. Tirzepatide: a medicine to manage type 2 diabetes and weight.
21. Medicines regulator approves up to 7.2 mg dose of semaglutide (Wegovy) for patients with obesity.
22. Single-dose 7.2 mg semaglutide (Wegovy) pen approved to treat adult patients with obesity.
23. The diagnostic utility of FIB-4 as a non-invasive tool for liver fibrosis.

Frequently Asked Questions